Order Article Reprints

Estévez-Vázquez O, Benedé-Ubieto R, Guo F, Gómez-Santos B, Aspichueta P, Reissing J, Bruns T, Sanz-García C, Sydor S, Bechmann LP, et al. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines. 2021; 9(10):1289. https://doi.org/10.3390/biomedicines9101289

Estévez-Vázquez, Olga, Raquel Benedé-Ubieto, Feifei Guo, Beatriz Gómez-Santos, Patricia Aspichueta, Johanna Reissing, Tony Bruns, Carlos Sanz-García, Svenja Sydor, Lars P. Bechmann, and et al. 2021. "Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)" Biomedicines 9, no. 10: 1289. https://doi.org/10.3390/biomedicines9101289

Estévez-Vázquez, O., Benedé-Ubieto, R., Guo, F., Gómez-Santos, B., Aspichueta, P., Reissing, J., Bruns, T., Sanz-García, C., Sydor, S., Bechmann, L. P., Maranillo, E., Sañudo, J. R., Vázquez, M. T., Lamas-Paz, A., Morán, L., Mazariegos, M. S., Ciudin, A., Pericàs, J. M., Peligros, M. I., ... Nevzorova, Y. A. (2021). Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines, 9(10), 1289. https://doi.org/10.3390/biomedicines9101289